Enterprise Therapeutics appoints Annabella Amatulli as Head of Regulatory Affairs
Enterprise Therapeutics appoints Annabella Amatulli as Head of Regulatory Affairs to support Phase 2 trial of lead asset ETD001 for cystic fibrosis, leveraging her extensive regulatory experience.
Reference News
Enterprise Therapeutics appoints Annabella Amatulli as Head of Regulatory Affairs
Enterprise Therapeutics appoints Annabella Amatulli as Head of Regulatory Affairs to support Phase 2 trial of lead asset ETD001 for cystic fibrosis, leveraging her extensive regulatory experience.